These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29262880)

  • 1. [Metabolomics of Chronic Myelogenous Leukemia Based on GC-MS].
    Yang BY; Li XL; Yao Y; Wang C; Chen SN; Wu XJ; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1585-1591. PubMed ID: 29262880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients.
    Yang B; Wang C; Xie Y; Xu L; Wu X; Wu D
    Cancer Sci; 2018 Mar; 109(3):777-784. PubMed ID: 29316075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite Profiling of the Plasma and Leukocytes of Chronic Myeloid Leukemia Patients.
    Karlíková R; Široká J; Friedecký D; Faber E; Hrdá M; Mičová K; Fikarová I; Gardlo A; Janečková H; Vrobel I; Adam T
    J Proteome Res; 2016 Sep; 15(9):3158-66. PubMed ID: 27465658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GC-TOF/MS-based metabolomics approach to study the cellular immunotoxicity of deoxynivalenol on murine macrophage ANA-1 cells.
    Ji J; Sun J; Pi F; Zhang S; Sun C; Wang X; Zhang Y; Sun X
    Chem Biol Interact; 2016 Aug; 256():94-101. PubMed ID: 27350164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary exploration of the metabolic profile and metabolic pathways in newly diagnosed multiple myeloma].
    Huang QL; Zhao RR; Yang BY; Jiang RY; Yang LL; Yan S; Fu ZZ; Wu DP; Wu XJ
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1369-1375. PubMed ID: 36575789
    [No Abstract]   [Full Text] [Related]  

  • 6. Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?
    Kelani R; Monem F
    Int J Lab Hematol; 2015 Oct; 37(5):723-8. PubMed ID: 26059167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Profiling of Plasma Samples from Women with Recurrent Spontaneous Abortion.
    Li X; Yin M; Gu J; Hou Y; Tian F; Sun F
    Med Sci Monit; 2018 Jun; 24():4038-4045. PubMed ID: 29898462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gas chromatography-mass spectrometry based urinary metabolomics in very low birth weight premature infants].
    Li ST; Huang XL; Wu SG; Ma YM; Shi CC; Xiao X; Hao H
    Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):434-438. PubMed ID: 28592011
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.
    Poddighe S; Murgia F; Lorefice L; Liggi S; Cocco E; Marrosu MG; Atzori L
    Int J Biochem Cell Biol; 2017 Dec; 93():148-155. PubMed ID: 28720279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.
    Pietarinen PO; Eide CA; Ayuda-Durán P; Potdar S; Kuusanmäki H; Andersson EI; Mpindi JP; Pemovska T; Kontro M; Heckman CA; Kallioniemi O; Wennerberg K; Hjorth-Hansen H; Druker BJ; Enserink JM; Tyner JW; Mustjoki S; Porkka K
    Oncotarget; 2017 Apr; 8(14):22606-22615. PubMed ID: 28186983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on plasma metabolomics profiling of depression in Chinese community-dwelling older adults based on untargeted LC/GC‒MS.
    Guo J; Han P; Zheng Y; Wu Y; Zheng K; Huang C; Wang Y; Chen C; Qi Y; Chen X; Tao Q; Zhai J; Guo Q
    Sci Rep; 2024 May; 14(1):10303. PubMed ID: 38705886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
    Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
    Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the serum metabolite signature in patients with rheumatoid arthritis using gas chromatography-mass spectrometry.
    Zhou J; Chen J; Hu C; Xie Z; Li H; Wei S; Wang D; Wen C; Xu G
    J Pharm Biomed Anal; 2016 Aug; 127():60-7. PubMed ID: 26879423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma metabolic profiling analysis of cyclophosphamide-induced cardiotoxicity using metabolomics coupled with UPLC/Q-TOF-MS and ROC curve.
    Yin J; Xie J; Guo X; Ju L; Li Y; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():428-435. PubMed ID: 27649503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.